Atlas Trials

New Combination Regimen of L-asparaginase, Dexamethasone, Ifosfamide, Cisplatin and Etoposide in NK/T-Cell Lymphoma

Clinical trial NCT00933673 · UNKNOWN

Trial details

NCT number
NCT00933673
Sponsor
Fudan University
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma
Start date
2009-06-01
Primary completion
2012-06-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.